Physician profile
Brian J Ipsen
NPI 1851371769
$65,679.02
in general payments reported to CMS, 2019-2025
34 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $457 · 2021: $5,579 · 2022: $11K · 2023: $32K · 2024: $4,942 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $9,821 · Food and Beverage: $4,936 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Honoraria: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,125.00 |
| Travel and Lodging | $9,820.74 |
| Food and Beverage | $4,936.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Honoraria | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $22,665.43 | 2020-2025 | Xvision |
| Orthofix Medical, INC. | $13,271.23 | 2020-2023 | |
| Seaspine Orthopedics Corporation | $12,928.12 | 2021-2022 | |
| Medtronic, INC. | $3,575.66 | 2021-2025 | Catalyft Pl Expandable Interbody System, Mazor X System, Unid_pass |
| Curvafix, INC. | $3,210.00 | 2025 | Curvafix Im Implant |
| Globus Medical, INC. | $2,974.07 | 2019-2025 | Excelsius Gps, Excelsius3d Imaging System, Sable |
| Medical Device Business Services, INC. | $1,961.24 | 2025 | Velys |
| Titan Surgical Group, LLC | $745.42 | 2024-2025 | |
| Stryker Corporation | $685.53 | 2019-2025 | Mako, Monterey Al, Gamma |
| Providence Medical Technology, INC. | $456.09 | 2023-2025 | |
| Nuvasive, INC. | $442.81 | 2019-2021 | |
| 4web, INC. | $321.83 | 2021-2023 | Spine Truss System |
| Pacira Pharmaceuticals Incorporated | $253.48 | 2021-2025 | Iovera, Exparel |
| Cerapedics INC. | $224.81 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Abbott Laboratories | $207.31 | 2019-2024 | Eterna |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $204.95 | 2024 | |
| Depuy Synthes Sales INC. | $204.35 | 2019-2022 | |
| Vb Spine LLC | $190.94 | 2025 | Cascadia Interbody System |
| Osseus Fusion Systems, LLC | $150.00 | 2024 | |
| Alphatec Spine, INC | $143.69 | 2019-2024 | |
| Si-Bone, INC. | $132.86 | 2019 | |
| Smith+Nephew, INC. | $118.61 | 2025 | Trigen Intertan |
| Carlsmed, INC. | $109.94 | 2025 | Aprevo |
| Aesculap Implant Systems, LLC | $91.68 | 2021 | |
| Nevro Corp. | $82.77 | 2019-2024 | Senza |
| Alafair Biosciences, INC. | $66.27 | 2022 | |
| Intrinsic Therapeutics | $64.68 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Boston Scientific Corporation | $61.01 | 2020-2021 | |
| Spineology INC. | $32.18 | 2024 | Optimesh Expandable Interbody Fusion System |
| Medtronic USA, INC. | $29.19 | 2019-2020 | |
| Kerecis Limited | $28.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Aesculap, INC. | $27.24 | 2025 | Aesculap |
| Zyla Life Sciences, INC. | $17.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,558,352.95 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ipsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.